ORCHARD THERAPEUTICS PLC's ticker is ORTX and the CUSIP is 68570P101. A total of 80 filers reported holding ORCHARD THERAPEUTICS PLC in Q3 2021. The put-call ratio across all filers is 4.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $7,845 | -28.7% | 21,145 | 0.0% | 0.00% | 0.0% |
Q3 2022 | $11,000 | -15.4% | 21,145 | -5.5% | 0.00% | 0.0% |
Q2 2022 | $13,000 | -18.8% | 22,375 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $16,000 | -46.7% | 22,375 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $30,000 | -14.3% | 22,375 | +45.3% | 0.00% | -33.3% |
Q3 2021 | $35,000 | – | 15,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
CHI Advisors LLC | 4,081,972 | $9,388,000 | 2.74% |
RA Capital Management | 11,028,722 | $25,366,000 | 0.35% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 6,949,416 | $15,984,000 | 0.31% |
Avidity Partners Management LP | 3,836,798 | $8,825,000 | 0.20% |
Casdin Capital, LLC | 2,575,000 | $5,923,000 | 0.15% |
Vivo Capital, LLC | 1,325,736 | $3,049,000 | 0.14% |
Artal Group S.A. | 1,803,858 | $4,149,000 | 0.09% |
Eversept Partners, LP | 569,581 | $1,310,036 | 0.09% |
GSA CAPITAL PARTNERS LLP | 374,811 | $862,000 | 0.09% |
PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,315 | $2,480,000 | 0.07% |